Madison Square Garden Sports (MSGS) is back in focus after filing a confidential Form 10 with the SEC to pursue a tax free spin off of the New York Knicks and New York Rangers.

The spin off news has landed on top of strong recent momentum, with the share price at $382.72 after a 12.32% 1 month share price return and a 102.13% 1 year total shareholder return. This suggests investors are reassessing both upside potential and risks.

If this kind of rerating has you curious about what else is moving, now is a good time to scan for other opportunities using our 20 top founder-led companies

With MSGS now trading at $382.72, only about 4.0% below the average analyst price target of $398.17 and with a 1 year total shareholder return above 100%, the key question is whether the spin off still leaves meaningful upside on the table or if the market is already pricing in future growth.

Most Popular Narrative: 9.8% Overvalued

With Madison Square Garden Sports closing at $382.72 against a narrative fair value of $348.60, the most followed storyline implies the stock is priced ahead of that fair value path and leans heavily on future earnings power to justify it.

The upcoming ramp-up in high-value national media rights fees for the NBA (beginning in fiscal '26) will offset the recent step-down in local media rights, positioning MSG Sports for an overall increase in recurring media revenue and supporting both revenue growth and higher net margins over the next several years.

Big media contracts. Higher margins. A future profit multiple that assumes serious earnings firepower. Want to see which specific growth and margin targets underpin that valuation story?

Result: Fair Value of $348.60 (OVERVALUED)

However, this story can be knocked off course if reduced local media rights fees or rising player and tax costs hit margins harder than analysts currently assume.

Next Steps

If this article has you torn between optimism and caution, now is the moment to check the balance of risks and rewards yourself with 1 key reward and 1 important warning sign

Looking for more investment ideas?

If you stop at MSGS, you might miss other stocks that better match your goals, so use the tools available and keep your watchlist working hard.

• Target potential value opportunities by scanning our market wide ideas through 46 high quality undervalued stocks.
• Prioritize strength and resilience by focusing on companies highlighted in the solid balance sheet and fundamentals stocks screener (47 results).
• Spot under the radar opportunities early with the screener containing 22 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.